<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biological Evaluation Plan - 100-000-BEP-001</title>
    <link rel="stylesheet" href="../../assets/css/summed-medtech-docs.css">
</head>

<body>
    <div class="a4-container">
        <div class="header-section">
            <img src="../../assets/images/Summed logo.png" alt="Summed Medtech 森迈医疗" class="company-logo"
                style="width: 80% !important; max-width: 300px !important; height: auto !important;">
            <div class="document-meta">
                <div><strong>Document No.:</strong> 100-000-BEP-001</div>
                <div><strong>Revision:</strong> 1.0</div>
            </div>
        </div>
        <h1>Biological Evaluation Plan for Auto-Injector (BEP)</h1>
        <table class="doc-info-table">
            <tr>
                <td width="25%"><strong>Document Name:</strong></td>
                <td colspan="3">Biological Evaluation Plan for Auto-Injector</td>
            </tr>
            <tr>
                <td><strong>Document No.:</strong></td>
                <td>100-000-BEP-001</td>
                <td><strong>Revision:</strong></td>
                <td>1.0</td>
            </tr>
        </table>
        <table class="signature-table">
            <tr>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ Jimmy Xu</div>
                        <div class="signature-title">Quality Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Prepared by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ Kevin Lo</div>
                        <div class="signature-title">R&D Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ ZY Gao</div>
                        <div class="signature-title">Production Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
            </tr>
            <tr>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ Grace Xue</div>
                        <div class="signature-title">Regulatory Affairs Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ Alex Chong</div>
                        <div class="signature-title">Business Development Department</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Reviewed by</div>
                    </div>
                </td>
                <td>
                    <div class="signature-block">
                        <div class="signature-name">/s/ Kayla Li</div>
                        <div class="signature-title">QA Manager (Approved by)</div>
                        <div class="signature-line"></div>
                        <div class="signature-label">Approved by</div>
                    </div>
                </td>
            </tr>
        </table>
        <div class="page-break"></div>

        <h2>Revision History</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="15%">Revision</th>
                    <th width="20%">Date</th>
                    <th width="45%">Description of Change</th>
                    <th width="20%">Reviser</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1.0</td>
                    <td>2024.11.12</td>
                    <td>New document</td>
                    <td>Jimmy Xu</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h2>1. Purpose</h2>
        <p>To collect and analyze all applicable information on raw materials and processing techniques used in the
            Xinjieda
            Auto-Injector. Based on the target market where the product is intended to enter, conduct biological
            evaluation
            planning for the Auto-Injector in accordance with GB/T 16886.1-2022 or ISO 10993-1:2018 or EN ISO
            10993-1:2020
            to ensure product safety and effectiveness.</p>

        <h2>2. Scope</h2>
        <p>This document is applicable to the biological evaluation of the Xinjieda Auto-Injector.</p>

        <h2>3. Product Description</h2>

        <h3>3.1 Product Name and Model</h3>
        <p><strong>Product Name:</strong> Auto-Injector</p>

        <h3>3.2 Intended Use and Target Population</h3>

        <h4>3.2.1 Intended Use</h4>
        <p>The Xinjieda Auto-Injector is suitable for use with Epinephrine (pre-filled 0.3 mL) for fluid delivery
            (intramuscular injection) for single patient or individual use only.</p>

        <h4>3.2.2 Target Population</h4>
        <p>Used for rescuing patients with emergency allergic reactions (such as anaphylactic shock, asthma), cardiac
            arrest, etc. (minors and adults). Contraindicated for patients with infection, inflammation, or broken skin
            at
            the injection site.</p>

        <h3>3.3 Product Composition and Structure</h3>
        <p>The Xinjieda Auto-Injector consists of front component, rear component, and cap component. The injection
            actuator
            in the rear component is composed of two parts: syringe carrier and power spring device.</p>

        <div style="text-align: center; margin: 20px 0;">
            <img src="../../assets/images/100-000-BEP-3-3.png" alt="Auto-Injector Product Structure"
                style="max-width: 100%; height: auto; border: 1px solid #ccc;">
            <p style="font-size: 9pt; color: #666; margin-top: 8px;">Figure 3.3-1: Auto-Injector Product Structure</p>
        </div>

        <h3>3.4 Packaging Information</h3>
        <p>Xinjieda Auto-Injector packaging includes support tray, carton, and outer shipping box.</p>

        <h3>3.5 Sterilization Information</h3>
        <p>The Xinjieda Auto-Injector is provided non-sterile and does not involve sterilization activities.</p>

        <div class="page-break"></div>

        <h3>3.6 Evaluation of Shelf Life and Transportation Storage Effects on Biological Compatibility</h3>
        <p><strong>Xinjieda Auto-Injector transportation and storage conditions:</strong></p>
        <p>1. Storage conditions: Temperature: 5°C ~ 40°C; Humidity: ≤ 80%</p>
        <p>2. Transportation mode: Air or land transport</p>
        <p>The biological compatibility of the Xinjieda Auto-Injector will not be affected by shelf life.</p>
        <p><strong>Justification:</strong> The polymer materials PC+ABS and PC used in the Xinjieda Auto-Injector
            product
            are not prone to degradation under normal use conditions. Based on their physical characteristics, the
            biological compatibility of polymer materials in the Xinjieda Auto-Injector will not be affected by shelf
            life.
        </p>

        <h3>3.7 Production Information</h3>

        <h4>3.7.1 Production Address</h4>
        <p>Both semi-finished and finished products of the Xinjieda Auto-Injector are produced in the production
            workshop of
            Jiaxing Summed Medtech Technology Co., Ltd. Production address: 5th Floor, Building 8, No. 313 Lingxiu Road,
            Luoxing Street, Jiashan County, Jiaxing City, Zhejiang Province.</p>

        <h4>3.7.2 Manufacturing Process</h4>
        <div style="text-align: center; margin: 20px 0;">
            <img src="../../assets/images/100-000-BEP-3.7.2.png" alt="Manufacturing Process Flowchart"
                style="max-width: 100%; height: auto; border: 1px solid #ccc;">
            <p style="font-size: 9pt; color: #666; margin-top: 8px;">Figure 3.7.2-1: Manufacturing Process Flowchart</p>
        </div>

        <div class="page-break"></div>

        <h2>4. Materials and Chemical Characterization</h2>

        <h3>4.1 Materials in Direct or Indirect Contact with Patients</h3>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="20%">Component Name</th>
                    <th width="25%">Material</th>
                    <th width="30%">Human Contact Type</th>
                    <th width="25%">Skin Contact Time (h)</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Washer Ring</td>
                    <td>Thermoplastic Elastomer (TPE)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Syringe Sleeve</td>
                    <td>Polycarbonate (PC)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Needle Cap</td>
                    <td>Polycarbonate-Acrylonitrile Copolymer (PC+ABS)</td>
                    <td>Direct Contact</td>
                    <td>≤ 24 h</td>
                </tr>
                <tr>
                    <td>Barrel</td>
                    <td>Polycarbonate-Acrylonitrile Copolymer (PC+ABS)</td>
                    <td>Direct Contact</td>
                    <td>≤ 24 h</td>
                </tr>
                <tr>
                    <td>Extended Barrel</td>
                    <td>Polycarbonate-Acrylonitrile Copolymer (PC+ABS)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Cap</td>
                    <td>Polycarbonate-Acrylonitrile Copolymer (PC+ABS)</td>
                    <td>Direct Contact</td>
                    <td>≤ 24 h</td>
                </tr>
                <tr>
                    <td>Iron Buckle</td>
                    <td>304 Stainless Steel (SUS304)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Rear Cap</td>
                    <td>Polycarbonate (PC)</td>
                    <td>Direct Contact</td>
                    <td>≤ 24 h</td>
                </tr>
                <tr>
                    <td>Execution Sleeve Rod</td>
                    <td>Polyoxymethylene (POM)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Sleeve</td>
                    <td>Polyoxymethylene (POM)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Plunger Rod</td>
                    <td>Polyoxymethylene (POM)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Plunger Spring</td>
                    <td>304 Stainless Steel (SUS304)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
                <tr>
                    <td>Needle Cap Spring</td>
                    <td>304 Stainless Steel (SUS304)</td>
                    <td>No Contact</td>
                    <td>/</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h3>4.2 Processing Aids, Process Residues, and Other Additives That May Remain on the Device</h3>
        <p>None.</p>

        <h2>5. Material Safety Research</h2>

        <h3>5.1 PC</h3>
        <p>Polycarbonate (PC) is a high-performance thermoplastic with excellent physical and chemical properties,
            widely
            used in industrial, electronic, medical, construction, and other fields. It has high strength and strong
            impact
            resistance. Long-term service temperature can reach 120°C, short-term can withstand > 140°C, but is easily
            corroded by organic solvents (such as acetone, strong alkali). Long-term exposure to ultraviolet light
            causes
            yellowing. Its cytotoxicity, sensitization, and irritation test results (such as MTT method, intracutaneous
            reaction test) comply with ISO 10993-5, -10, -23 requirements. Generally has good biocompatibility, but
            attention should be paid to residual monomer bisphenol A (BPA) and potential hydrolytic degradation risks.
        </p>
        <p>See Appendix A "PC Material Review Report"</p>

        <h3>5.2 PC+ABS</h3>
        <p>Polycarbonate-Acrylonitrile-Butadiene-Styrene Copolymer (PC+ABS) combines the strength and heat resistance of
            polycarbonate (PC) with the toughness of ABS, widely used in medical devices (such as housings, handles,
            respiratory equipment, etc.). Its cytotoxicity, sensitization, and irritation test results (such as MTT
            method,
            intracutaneous reaction test) comply with ISO 10993-5, -10, -23 requirements. Generally has good
            biocompatibility, but attention should be paid to the risk that residual monomers (acrylonitrile, bisphenol
            A)
            may affect results.</p>
        <p>PC+ABS is widely used in short-term contact devices, suitable for non-implantable devices (such as equipment
            housings, handles, respiratory masks, etc.). PC+ABS has been successfully used in market-approved devices
            such
            as insulin pens and nebulizer housings. The expected biological response level is acceptable.</p>
        <p>See Appendix B "PC+ABS Material Review Report"</p>

        <div class="page-break"></div>

        <h2>6. Chemical Characterization Testing</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="50%">Component Category</th>
                    <th width="50%">Risk Substances</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>PC Components</td>
                    <td>Bisphenol A (BPA) residues, etc.</td>
                </tr>
                <tr>
                    <td>PC+ABS Components</td>
                    <td>Bisphenol A (BPA), acrylonitrile monomer, etc.</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h2>7. Biological Evaluation Process</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="5%">No.</th>
                    <th width="25%">Decision or Step</th>
                    <th width="15%">Answer</th>
                    <th width="55%">Specific Steps</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Decision 1</td>
                    <td>Is it in direct or indirect contact with patients?</td>
                    <td>☑ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 1; if answer is "No", no biological evaluation is required.
                    </td>
                </tr>
                <tr>
                    <td>Step 1</td>
                    <td>Obtain physical/chemical information of materials and consider chemical characterization (ISO
                        10993-18).</td>
                    <td>/</td>
                    <td>Identify information on raw materials in direct or indirect contact with the human body. See
                        Section
                        6 "Materials and Chemical Characterization" and Section 7 "Physical Characterization" for
                        details.
                    </td>
                </tr>
                <tr>
                    <td>Decision 2</td>
                    <td>Is the material the same as a commercially available device material?</td>
                    <td>☐ Yes ☑ No</td>
                    <td>If answer is "Yes", proceed to Decision 3; if answer is "No", proceed to Decision 6.</td>
                </tr>
                <tr>
                    <td>Decision 3</td>
                    <td>Is the same manufacturing process and sterilization (type/process details) present?</td>
                    <td>☐ Yes ☑ No</td>
                    <td>If answer is "Yes", proceed to Decision 4; if answer is "No", proceed to Decision 6.</td>
                </tr>
                <tr>
                    <td>Decision 4</td>
                    <td>Are the same geometric and physical characteristics present?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Decision 5; if answer is "No", proceed to Decision 6.</td>
                </tr>
                <tr>
                    <td>Decision 5</td>
                    <td>Is the same human contact and clinical use present?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 6; if answer is "No", proceed to Decision 6.</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <table class="data-table">
            <thead>
                <tr>
                    <th width="5%">No.</th>
                    <th width="25%">Decision or Step</th>
                    <th width="15%">Answer</th>
                    <th width="55%">Specific Steps</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Decision 6</td>
                    <td>Has a safe use history of the material been established and physical properties not changed?
                    </td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 6; if answer is "No", proceed to Step 2 or Decision 10.</td>
                </tr>
                <tr>
                    <td>Step 2</td>
                    <td>Conduct chemical characterization testing</td>
                    <td></td>
                    <td>Perform chemical analysis of extractables according to ISO 10993-18. See Section 9 "Chemical
                        Characterization Testing". Then proceed to Decision 7.</td>
                </tr>
                <tr>
                    <td>Decision 7</td>
                    <td>Is there sufficient toxicological data for all chemicals in the device?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Decision 8; if answer is "No", proceed to Decision 10.</td>
                </tr>
                <tr>
                    <td>Decision 8</td>
                    <td>Are these data applicable to chemical mixtures?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Decision 9; if answer is "No", proceed to Decision 10.</td>
                </tr>
                <tr>
                    <td>Decision 9</td>
                    <td>Are these data relevant to contact dose and route?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 6; if answer is "No", proceed to Decision 10.</td>
                </tr>
                <tr>
                    <td>Decision 10</td>
                    <td>Is the device a single metal/alloy/ceramic?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Decision 11; if answer is "No", proceed to Step 3.</td>
                </tr>
                <tr>
                    <td>Decision 11</td>
                    <td>Does the metal/alloy/ceramic contain potentially toxic substances at levels of concern (such as
                        Pb,
                        Ni, Cr, Zr)?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Decision 12; if answer is "No", proceed to Decision 13.</td>
                </tr>
                <tr>
                    <td>Decision 12</td>
                    <td>Is the risk relevant to the population?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 3; if answer is "No", proceed to Step 6.</td>
                </tr>
                <tr>
                    <td>Decision 13</td>
                    <td>Is material standard certification sufficient?</td>
                    <td>☐ Yes ☐ No</td>
                    <td>If answer is "Yes", proceed to Step 6; if answer is "No", proceed to Step 3.</td>
                </tr>
                <tr>
                    <td>Step 3</td>
                    <td>Further evaluate the device based on chemical properties and contact category and time</td>
                    <td></td>
                    <td>☐ Surface contact: ☐ Intact skin ☐ Mucous membrane ☐ Broken or injured surface<br>
                        ☐ External communication: ☐ Blood path, indirect tissue/bone<br>
                        ☐ Implant: ☐ Tissue/bone<br>
                        ☐ Contains carcinogenic, mutagenic, and/or reproductive toxic substances<br>
                        ☐ New materials, materials with known reproductive or developmental toxicity, used in specific
                        populations (such as pregnant women), device materials with potential for retention in
                        reproductive
                        organs<br>
                        ☐ Has degradation potential<br>
                        ☐ Extracorporeal circulation devices</td>
                </tr>
                <tr>
                    <td>Step 4</td>
                    <td>Selection of biological endpoints</td>
                    <td></td>
                    <td>See Section 13 "Selection of Biological Tests"</td>
                </tr>
                <tr>
                    <td>Step 5</td>
                    <td>Testing and/or justification for waiving recommended tests</td>
                    <td></td>
                    <td>Conduct biological testing according to selected endpoints. If a test is waived, justification
                        for
                        waiver should be provided.</td>
                </tr>
                <tr>
                    <td>Step 6</td>
                    <td>Conduct biological risk assessment, biological evaluation completed</td>
                    <td></td>
                    <td>Complete the risk assessment and risk/benefit analysis in the "Risk Management Report" based on
                        available literature, test data, and other information, and complete the biological evaluation
                        report.</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h2>8. Selection of Biological Tests</h2>
        <table class="data-table">
            <thead>
                <tr>
                    <th width="30%">Evaluation Item</th>
                    <th width="35%">Applicable Components</th>
                    <th width="35%">Applicable Standard</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Chemical Characterization</td>
                    <td>All components in contact with skin</td>
                    <td>ISO 10993-18</td>
                </tr>
                <tr>
                    <td>Cytotoxicity</td>
                    <td>All components in contact with skin</td>
                    <td>ISO 10993-5</td>
                </tr>
                <tr>
                    <td>Skin Sensitization</td>
                    <td>All components in contact with skin</td>
                    <td>ISO 10993-10</td>
                </tr>
                <tr>
                    <td>Skin Irritation</td>
                    <td>All components in contact with skin</td>
                    <td>ISO 10993-23</td>
                </tr>
            </tbody>
        </table>

        <div class="page-break"></div>

        <h2>9. Appendices</h2>
        <p>A. "PC Material Review Report"</p>
        <p>B. "PC+ABS Material Review Report"</p>

        <div class="footer">
            <p>Summed Medtech 森迈医疗 | Document No.: 100-000-BEP-001 | Revision: 1.0</p>
        </div>
    </div>
</body>

</html>